SCHEMBL4965028

SCHEMBL4965028

NS(=O)(=O)C1C=CC=CC1c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.37
CA1 P00915 9/20 0.37
CA9 Q16790 7/20 0.37
CA5A P35218 4/20 0.37
CA4 P22748 3/20 0.37
CA6 P23280 3/20 0.37
CA12 O43570 3/20 0.37
CA7 P43166 2/20 0.37
CA14 Q9ULX7 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
CA3 P07451 1/20 0.37
PLA2G7 Q13093 1/20 0.37
CA13 Q8N1Q1 1/20 0.37
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C9 P11712 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30311727 0.72 RECQL (0.40) MAPTCYP2C9LMNATP53CYP1A2
SCHEMBL21162132 0.67 MAOB (0.41) MAPTKDM4EHPGDCYP2C9LMNA
SCHEMBL14652740 0.67 MAOB (0.41) MAPTKDM4EHPGDCYP2C9LMNA
SCHEMBL15583493 0.66 CYP1A2 (0.38) MAPTCYP2C9LMNATP53CYP1A2
SCHEMBL4794296 0.64 LMNA (0.39) MAPTLMNATP53CYP1A2CYP3A4
SCHEMBL17518709 0.64 SMN1; SMN2 (0.33) CA2MAPTLMNATP53CYP1A2
SCHEMBL28036409 0.63 CYP2C19 (0.42) CYP2C9LMNACYP1A2CYP3A4KDM1A
SCHEMBL18570252 0.63 RECQL (0.33) MAPTCYP2C9LMNATP53CYP1A2
SCHEMBL29155608 0.63 POLB (0.35) CA4MAPTKDM4ELMNATP53
SCHEMBL5268971 0.63 EDNRA (0.41) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100364971-C Pyrrolidin-2-ones as factor Xa inhibitors GLAXO GROUP LTD (GB) 2008-01-30 CN claimed
EP-1888517-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR AstraZeneca AB (SE) 2008-02-20 EP disclosed
CN-100364971-C Pyrrolidin-2-ones as factor Xa inhibitors GLAXO GROUP LTD (GB) 2008-01-30 CN disclosed
WO-2006126939-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR ASTRAZENECA AB (SE) 2006-11-30 WO disclosed
CN-1620434-A Pyrrolidine-2-ones as factor Xa inhibitors GLAXO GROUP LTD (GB) 2005-05-25 CN disclosed
EP-1456172-A1 PYRROLIDINE-2-ONES AS FACTOR XA INHIBITORS GLAXO GROUP LIMITED (GB) 2004-09-15 EP disclosed
WO-2003053925-A1 PYRROLIDINE-2-ONES AS FACTOR XA INHIBITORS GLAXO GROUP LIMITED (GB) 2003-07-03 WO disclosed
WO-1998004260-A1 SUBSTITUTED BIPHENYL SULFONAMIDE ENDOTHELIN ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-02-05 WO disclosed